Objective. To investigate the influence of traumatic brain injury (TBI) on immune function and viability of human peripheral monocytes in polytraumatized patients. Material and methods. This was a prospective, randomized, controlled clinical study conducted in a Level I trauma center. Multiply injured patients (n 042; mean age 42.4915.5 years) with a mean Injury Severity Score (ISS) of 32.399.6 were compared to healthy controls (n 020; mean age 36.398.4 years). The methods used were clinical evaluation, scoring of injury severity (ISS, abbreviated injury scores), multiple organ dysfunction score, realtime reverse transcription polymerase chain reaction, Western blotting and fluorescent-activated cell sorting analyses of negatively isolated monocytes. The main outcome measures were overall clinical outcome, terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL) staining, expression of the Fas and tumor necrosis factor receptor I, expression of the mitochondrial proteins Bax and Bcl-2, caspase-8, -9 and -3/7 activity and the level of C5a throughout a 5-day post-trauma observation period. Results. Apoptosis of peripheral blood monocytes was evident in both patient cohorts, as demonstrated by positive TUNEL staining and significant increases in caspase-3/7 activation. Trauma patients with TBI ('TBI patients) presented with a higher incidence of sepsis. Moreover, only 'TBI patients demonstrated significant upregulation of pro-apoptotic mediators (increased Fas receptor) and downregulation of anti-apoptotic mediators (decreased Bcl-2) via caspase-dependent signaling (increased caspase-8 and -9) when compared to both trauma patients without TBI ((TBI patients) and healthy controls. In contrast, (TBI patients demonstrated significantly higher plasma concentrations of anaphylatoxin C5a on Day 0. Conclusions. Multiply injured patients show significant monocyte apoptosis, which may particularly promote the development of post-traumatic complications in a caspase-dependent manner in 'TBI patients. The role of increased C5a and complement-associated monocyte apoptosis in (TBI patients requires further investigation.